House passes psychedelics amendments to embed a Trump executive order in law and extend a military research program on psychedelic treatments through 2033

U.S. House lawmakers approved psychedelics-related amendments that would write a Trump executive order into federal law and extend a military research program on psychedelic-assisted treatments through 2033. The measures center on accelerating federal action around promising therapies for service members and veterans, especially in relation to trauma and other serious mental health conditions. The policy move ties psychedelic reform to defense and veterans' health priorities rather than broad drug legalization. Military-backed research has increasingly focused on compounds such as MDMA and psilocybin, which are being studied for conditions like PTSD, depression, and traumatic brain injury. Embedding the executive order in statute could make the federal push more durable across administrations, while extending the Pentagon-linked program signals continuing bipartisan interest in evidence-driven psychedelic medicine within national security and veteran care systems.